Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study
Lists
Only you see this
Abstract
The primary outcome of the three tailored, 9-month, all-oral, 5-drug regimens was satisfactory in the vast majority of MDR-TB and pre-XDR-TB patients, with manageable and reversible AEs.
BibTeX
@article{fu2023selecting,
author = {Liang Fu and Xilin Zhang and Juan Xiong and Feng Sun and Taoping Weng and Yang Li and Peize Zhang and Hui Li and Qianting Yang and Yi Cai and Hancheng Liang and Qiuqi Chen and Zhaoqing Wang and Lei Liu and Xinchun Chen and Wenhong Zhang and Guofang Deng},
title = {{Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study}},
journal = {International Journal of Infectious Diseases},
year = {2023},
doi = {10.1016/j.ijid.2023.08.001},
}Loading related content...